HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
Authors:
Open Access
- 6 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e54917
Abstract
Highly active antiretroviral therapy (HAART) has significantly decreased mortality among Chinese HIV patients. However, emerging HIV drug resistance (HIVDR) poses a growing threat to the long-term success and durability of HAART. Three cross-sectional surveys were conducted across the country from 2004 to 2006, respectively. Patients completed a questionnaire and provided blood for CD4 cell count, HIV viral load (VL), and HIV resistance genotyping. Factors associated with HIVDR were identified by logistic regression. 3667 unique patients were included across the three surveys. Among 2826 treatment-experienced patients, median duration of treatment was 17.4 (IQR 8.6–28.4) months and HIVDR was identified in 543 (19.2%). Factors significantly associated with HIVDR included ART drug distribution location, CD4 cell count, initial HAART regimen, self-reported medication adherence, and province. Virologic failure increased over time on therapy but a significant proportion of patients in failure had no resistance mutations identified, suggesting that treatment adherence is suboptimal and must be emphasized. Due to the significantly higher risk of HIVDR in certain provinces, additional steps to reduce HIVDR should be taken.Keywords
This publication has 18 references indexed in Scilit:
- Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyThe Lancet Infectious Diseases, 2011
- Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09International Journal of Epidemiology, 2010
- HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985–2008PLOS ONE, 2010
- Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sitesTropical Medicine & International Health, 2010
- The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-Infected Individuals in ChinaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Cohort Profile: The Chinese national free antiretroviral treatment cohortInternational Journal of Epidemiology, 2009
- Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in AngolaJournal of Antimicrobial Chemotherapy, 2008
- The Chinese free antiretroviral treatment program: challenges and responsesAIDS, 2007
- Genetic Diversity and Drug Resistance of Human Immunodeficiency Virus Type 1 (HIV-1) Strains Circulating in ShanghaiAIDS Research and Human Retroviruses, 2007
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006